Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03153436Phase 2Completed
Phase 2, open-label trial of myo-inositol in male infertility, sponsored by Sohag University. Primary endpoint: Cryo-survival rate at 7 months. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03153436.